EGFR and breast carcinoma: The PI3K-Akt signaling pathway, MAPK signaling pathway, pathways in cancer, HIF-1 signaling, and EGFR tyrosine kinase inhibitor resistance stand out as the most relevant among the various breast cancer-related signaling pathways covered by these pathways.